◀ The Principal Blog

Posts from the ‘Institutional Investors’ category

Medical Care Inflation Fact and Fiction



Healthcare costs are a key issue for Americans. Mylan’s CEO Heather Bresch recently faced some tough questions from Congress over the increase in price of the Epipen — a drug used to treat severe allergic reactions — from the reasonable $100 in 2007 to the absurd $600 plus today. Former drug…

Read more

A New Chapter in the History of Investing



As a discipline, investing has evolved since the 1970s, witnessing the advancement of new asset classes, new diversification tools, new benchmarks, new investor segments, and new geographies. The key drivers of this evolution have been regulation, pension reforms, globalisation, and rising…

Read more

Recent